Recent Finacing
Recent Raise
CoDa Therapeutics is a clinical-stage biopharmaceutical company developing topical gap-junction modulators, including Nexagon®, for chronic wounds, inflammation and tissue repair, with ongoing IND-supported clinical trials and patents.
